Search results
Results from the WOW.Com Content Network
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
The Washington Post submitted a complaint against Coler's registration of the site with GoDaddy under the UDRP, and in 2015, an arbitral panel ruled that Coler's registration of the domain name was a form of bad-faith cybersquatting (specifically, typosquatting), "through a website that competes with Complainant through the use of fake news ...
Visitors to malaysiakini.com in 2008. Malaysiakini (English: "Malaysia Now") is an online news portal in Malaysia which was established in 1999. It is published in Malay, English, Chinese and Tamil, and is among the most read news portals in Malaysia.
Free Malaysia Today (FMT) is an independent, bilingual news online portal with content, in both English and Bahasa Malaysia (Malay), with a focus on Malaysian current affairs, published since 2009. [ 1 ] [ 2 ] It is one of Malaysia 's most accessed news sites with monthly visits of 11.83 million.
The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice ...
Daily Express Logo of Daily Express (Malaysia) Type Daily newspaper Format Berliner Publisher Sabah Publishing House Sdn. Bhd Founded 1 March 1963 Political alignment Independent Language English, Malay Headquarters Kota Kinabalu, Sabah, Malaysia Circulation 33,790 (daily) July–December 2013 Website dailyexpress.com.my The Daily Express is an English-language newspaper in Sabah, Malaysia and ...
New Sabah Times – English, Malay, and Kadazan-Dusun daily in Sabah, ceased publication on 31 December 2020; Sarawak Tribune – suspended in 2006, but has since been relaunched as the New Sarawak Tribune in 2010. Shin Min Daily News – Malaysia's first Chinese-language tabloid newspaper; publication ceased in 1994
By Blake Brittain (Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia ...